The effect of aromatherapy with lavender on colposcopy health and pai
Phase 3
Not yet recruiting
- Conditions
- Anxiety caused by colposcopy.Anxiety disorder due to known physiological conditionF06.4
- Registration Number
- IRCT20240724062526N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
Patients referred for colposcopy
Exclusion Criteria
Acute pain at the time of completing the questionnaire
Having psychiatric disorders including anxiety
Mental retardation
Blindness and deafness
History of eczema and allergies to plants
History of migraine and chronic headaches
Impaired sense of smell
Use of sedatives and narcotics
A history of severe mental stress around the time of colposcopy (such as the death of a loved one)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie lavender's anxiolytic effects in colposcopy patients with F06.4 anxiety disorder?
How does aromatherapy with lavender compare to benzodiazepines in reducing pre-colposcopy anxiety and pain?
Are there specific biomarkers that predict response to lavender aromatherapy in anxiety due to physiological conditions?
What are the potential adverse events associated with lavender aromatherapy in gynecological procedures?
What combination therapies or alternative compounds show promise for managing colposcopy-related anxiety and pain?